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Abstract: BRI3 (brain protein I3) is one of the Wnt/β-catenin pathway target genes as indicated by the results of serial analysis of gene
expression (SAGE) and microarray analyses performed in our laboratory. The Wnt/β-catenin signaling pathway is an evolutionarily
conserved pathway, which has important functions in early vertebrate development, axis formation, cellular proliferation, and
morphogenesis. Previous studies showed that BRI3 expression is upregulated at both mRNA and protein levels upon β-catenin
activation by various approaches, such as lithium treatment and overexpression of Wnt ligands in Huh7 (hepatocellular carcinoma) cell
lines. Moreover, with regard to the previous literature, BRI3 was found to have a very important role in the TNFα-mediated cell death
pathway. In this study, we screened a human liver cDNA library by yeast two-hybrid assay using BRI3 protein as bait, with the aim of
finding novel interaction partners of BRI3. Library screening by yeast mating resulted in the identification of three candidate positive
clones. Among these, IFITM3 and MGAT1 proteins were confirmed as interaction partners by using cotransformation in yeast cells and
coimmunoprecipitation from mammalian cell lines. Considering the poor functional characterization of BRI3 to date, identification of
novel BRI3-interacting proteins is an essential first step in determining the action mechanism of BRI3 with respect to the Wnt/β-catenin
pathway.
Key words: Wnt/β-catenin signaling, BRI3, SAGE, hepatocellular carcinoma, yeast two-hybrid, IFITM3, MGAT1

1. Introduction
BRI3 (brain protein I3) was originally identified as
a 125-amino-acid transmembrane protein that is
overexpressed in TNFα-treated L929-murine fibrosarcoma
cells (Wu et al., 2003). The blocking of new BRI3 protein
synthesis by using BRI3-antisense RNA resulted in
increased resistance of these cells to TNF-induced cell
death with magnitude greater than 1000-fold. Although
the exact action mechanism of BRI3 within the TNFinduced cell death pathway still remains unknown, it is
hypothesized that BRI3 synthesis might act as a negative
checkpoint of this pathway (Wu et al., 2003).
BRI3 has been selected among the potential Wnt/βcatenin signaling pathway targets based on serial analysis
of gene expression (SAGE) screening and an equivalent
microarray screening (Kavak et al., 2010). In order to
identify novel transcriptional targets of the Wnt/β-catenin
signaling pathway, these transcriptome profile analyses
were performed in our laboratory using stable Huh7
(hepatocellular carcinoma) cell lines overexpressing a
mutant form of β-catenin, which is degradation-resistant.
BRI3 was among the several putative Wnt/β-catenin target

genes that were detected with differential expression profiles
upon β-catenin induction in the Huh7 cell line. Moreover,
lithium treatment of Huh7 cell lines and overexpression
of the Wnt ligands in the same cell lines resulted in the
upregulation of BRI3 gene expression, as determined
by quantitative RT-PCR (Kavak et al., 2010). The results
obtained from luciferase reporter gene assay, in which
BRI3 promoter activity was found to be increased due to
overexpression of β-catenin, also supported the previous
data. Additionally, chromatin immunoprecipitation
(ChIP) assays indicated that β-catenin interacts with the
BRI3 promoter region in Huh7 cell lines and in mouse
liver tissue.
Wnt signaling is an evolutionarily conserved pathway
in various organisms from worms to mammals and plays
important roles in several biological processes such
as development, differentiation, cellular proliferation,
morphology, motility, and cell fate. Wnt proteins constitute
a family of secreted cysteine-rich glycoproteins that
exhibit distinct expression patterns in embryo and adult
organisms (Cadigan and Nusse, 1997). In mammals, 12
distinct Wnt protein families exist, which might induce at
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least four different pathways: the canonical Wnt/β-catenin/
TCF pathway, and the noncanonical pathways, namely
the Wnt/calcium, Wnt/planar cell polarity (PCP), and
Wnt/G protein pathways (Wodarz et al., 1998). However,
alterations of the canonical Wnt/β-catenin/TCF pathway
are implicated in tumorigenesis.
If the Wnt/β-catenin signaling pathway is not
activated, cytoplasmic β-catenin levels are kept low
through continuous proteasome-mediated degradation,
which is controlled by a multiprotein complex containing
glycogen synthase kinase 3β (GSK-3β), adenomatous
polyposis coli (APC), and axin. In the absence of a Wnt
signal, β-catenin is present in the axin complex. In this
complex, cytosolic β-catenin, but not the cadherin-bound
β-catenin, is continuously phosphorylated, ubiquitinated,
and degraded by proteasome (Rubinfeld et al., 1993).
The activation of the Wnt/β-catenin signaling pathway
is initiated by binding of a Wnt ligand to the Frizzled
receptor (Fz) and low-density lipoprotein receptor-related
protein (LRP) 5/6 coreceptor. In this case, Dishevelled
(Dsh) inhibits the GSK-3β-dependent phosphorylation
of β-catenin in response to the Wnt signal. Consequently,
β-catenin is dissociated from the destruction complex
and starts to accumulate in the cytosol. The accumulated
β-catenin is then translocated into the nucleus, binds to the
T-cell factor/lymphoid enhancer factor (TCF/LEF) family
of transcription factors, and activates the expressions of
several cell cycle- and differentiation-related target genes
such as axin, c-myc, and cyclin D1 (Behrens et al., 1996).
In this study, we identify two novel BRI3-interacting
proteins, which is an essential first step in determining
the action mechanism of BRI3 with respect to the Wnt/βcatenin pathway.

The mated culture was spread on SD/-Ade/-His/-Leu/Trp plates (200 µL per 150-mm plate). The plates were
incubated at 30 °C for 5–6 days.
The yeast host strains used in this study were
obtained from Clontech (USA): AH109 (genotype:
MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ,
gal80Δ, LYS2::GAL1UAS-GAL1TATA-HIS3,GAL2UASGAL2TATA-ADE2,URA3 :: MEL1UAS-MEL1TATA-lacZ)
and Y187 (genotype: MATα, ura3-52, his3-200, ade2101, trp1-901, leu2-3, 112, gal4Δ, met–, gal80Δ, URA3 ::
GAL1UAS-GAL1TATA-lacZ).

2. Materials and methods
2.1. Library screening by yeast mating
The Matchmaker GAL4-Yeast Two-Hybrid System
(Clontech) was used together with the pretransformed
human liver cDNA library (Clontech). A fresh and large
colony of the bait strain (AH109 [pGBKT7/Bri3]) was
inoculated into 50 mL of SD/-Trp liquid medium and
incubated at 30 °C with shaking (230–250 rpm) until the
OD600 reached 0.8. The cells were centrifuged at 1000 × g
for 5 min and then resuspended in 5 mL of SD/-Trp. In a
sterile 2-L flask, a 1-mL aliquot of the library strain was
combined with 5 mL of bait strain. Then 45 mL of 2X
YPDA liquid medium was added to the flask and incubated
at 30 °C for 22 h with slow shaking (50 rpm). After 22 h
the cells were centrifuged. The 2-L flask was rinsed twice
with 50 mL of 0.5X YPDA. The rinses were then combined
and used to resuspend the pelleted cells. The cells were
again centrifuged for 10 min and all pelleted cells were
resuspended in 10 mL of 0.5X YPDA liquid medium.

2.4. Coimmunoprecipitation
HEK293T cells were transfected with plasmids carrying
the tagged versions of the genes. First, a 1:1 suspension
of protein G agarose bead slurry was washed with icecold lysis buffer three times. Anti-HA antibody diluted
in 1X PBS was incubated with 30 µL of protein G agarose
beads for 4 h at room temperature by swinging head-overtail. After the incubation, the antibody-bead complexes
were washed 3 times with Co-IP lysis buffer at 4 °C by
spinning, and then 48 h after transfection adherent cells
were washed with ice-cold 1X PBS and then lysed in icecold Co-IP lysis buffer supplemented with 1X protease
inhibitor cocktail and 1 mM PMSF. The cells on the plate
were harvested using a cell scraper and transferred to an
Eppendorf tube. Complete lysis was assured by pipetting
the solution several times and incubating on ice for 30 min.
The cell lysate was centrifuged at 12,000 rpm for 15 min at
4 °C; 30–40 µL of input was obtained and the remaining
supernatant was added to the antibody-bead complex in
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2.2. Yeast colony PCR
The identification of the cDNA clone in the prey vector
was done by yeast colony PCR and sequencing of the PCR
samples. For this purpose, single and fresh colonies were
picked with sterile pipette tips and resuspended in 3 µL of
NaOH (25 mM) in separate PCR tubes. Liquid nitrogen
was used to quick-freeze the samples. Then the samples
were placed into the PCR machine and boiled at 95 °C
for 10 min. Master mix was prepared using the pACT2FpACT2R primer pair and distributed to the tubes. For the
PCR reaction, the following cycling conditions were used:
94 °C for 5 min, 30 cycles [94 °C for 30 s, 55 °C for 30 s, 72
°C for 1 min], 72 °C for 10 min, hot-start at 94 °C.
2.3. Cotransformation of competent yeast cells
Clontech’s YeastMaker Yeast Transformation System was
used according to the manufacturer’s protocol for all
transformations of yeast cells. A PEG/LiAc (polyethylene
glycol 3350/lithium acetate)-based method was applied
for the preparation and transformation of competent
yeast cells. For the cotransformation of the bait and prey
vectors, 0.2 µg of each vector was used together with 5 µL
of herring testes carrier DNA (10 mg/mL).
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Eppendorf tubes. The tubes were allowed to swing headover-tail at 4 °C in a cold room overnight. The next day,
the antibody-bead-protein complexes were washed three
times with Co-IP lysis buffer and once with 1X PBS. The
final supernatant was removed and the tubes were stored
at –80 °C for later use in SDS-PAGE analysis.
2.5. Confocal microscopy
Huh7 cells grown on 18-mm coverslips inside 12-well
culture plates were used for imaging with confocal
microscopy. The cells were transfected with the plasmids
expressing the fluorescent-tagged versions of our proteins
of concern using the Turbofect transfection reagent
(Thermo Scientific) according to the manufacturer’s
instructions. Forty-eight hours after transfection, the
growth medium was aspirated and the cells were washed
with 1X PBS. Thereafter, 250–300 µL of ice-cold 4%
paraformaldehyde was added to the cells in each well.
The cells were incubated at room temperature for 20
min without shaking. Then 4% paraformaldehyde was
aspirated and the cells were washed with 1X PBS three
times. Next, 250 µL of DAPI solution (1 µg/mL) was added
to the cells. The cells were incubated with DAPI for 1–2
min and then washed with 1X PBS three times. Using
forceps, the coverslips inside the wells were placed onto
the slides with 3 µL of mounting medium. After drying for
a few minutes, nail polish was applied to intersection areas
around the coverslips and the samples were analyzed with
the confocal microscope.
3. Results
The candidate transcriptional targets of the canonical
Wnt/β-catenin pathway were determined previously in
our laboratory by using genome-wide microarray analyses
and SAGE techniques (Kavak et al., 2010). BRI3 has been
selected as being one of the most prominent targets of Wnt/
β-catenin pathway due to its transcriptional upregulation
in hepatocellular carcinoma cells overexpressing the
mutant and degradation-resistant form of β-catenin.
This upregulation was further supported by experimental
evidence coming from q-RT-PCR analyses, ChIP assay,
luciferase reporter assay, and treatment of cells with
lithium chloride, which leads to the activation of Wnt/βcatenin pathway (Kavak et al., 2010).
Yeast two-hybrid assay was performed as a first step
in order to determine the interaction partners of the BRI3
protein. For this purpose, a pretransformed human liver
cDNA library was used. Yeast mating was performed
between the MATa strain (AH109) transformed with the
pGBKT7/BRI3 bait vector and the MATα strain (Y187)
pretransformed with the human liver cDNA library. The
estimated number of independent clones screened by this
mating was calculated to be 2.6 × 106. The mated culture
was allowed to grow on SD/-Ade/-His/-Leu/-Trp agar

plates, so that high stringency was used in order to detect
the activation of the reporter genes ADE2 and HIS3. The
positive clones obtained from yeast mating were restreaked
to single colonies on SD/-Ade/-His/-Leu/-Trp agar plates
with X-α-Gal in order to confirm the phenotype. As a
result of two-hybrid interactions, in addition to ADE2 and
HIS3 reporter genes, MEL1, which encodes the enzyme
α-galactosidase, can also be expressed. Yeast colonies
that express MEL1 turn blue in the presence of the
chromogenic substrate X-α-Gal. Therefore, those single
blue colonies were analyzed primarily for being candidate
positive colonies (Figure 1A).
The yeast colonies selected in the blue/white screening
were subjected to colony PCR analysis in order to identify
the corresponding cDNA inserts. PCR products that
corresponded to single and clear bands were sequenced
and the identities of those cDNA clones were revealed
by performing a BLAST search of the raw outputs over
various databanks in order to find significant matches.
A list of all candidate proteins determined as putative
interaction partners is given as supplementary material
(Table S1). Several candidates from this list have abundant
protein expression levels in the liver cDNA library and
are mostly characterized as “sticky” proteins in yeast twohybrid screenings with respect to the previous literature;
therefore, these proteins were eliminated as being false
positives. Eventually, three candidate cDNA clones
(IFITM3, IL-7R, and MGAT1) were determined for
further analysis. The vectors containing the cDNA insert
of interest were isolated from the corresponding yeast
colonies. Then the bait vector together with the vector
containing the candidate cDNA clone were cotransformed
into the yeast cells for confirmation. The transformed yeast
cells were spread on nutrient selective media (SD/-Ade/His/-Leu/-Trp) and tested for their ability to grow into
colonies. As a result, cotransformation yielded colonies
for two out of three selected cDNA clones (Figure 1B).
Thus, IFITM3 and MGAT1 were determined as candidate
interacting partners for BRI3.
The BRI3 protein has two isoforms. The a-isoform
is 125 amino acids in length. On the other hand, the
b-isoform of BRI3 is a 98-amino-acid polypeptide
sharing the same N-terminus but has a totally distinct
C-terminus compared to the a-isoform (Figure 2).
Coimmunoprecipitation has been performed in order
to test the interaction of the two BRI3 isoforms with the
candidate proteins, which were revealed as the result of
yeast two-hybrid assay. For this purpose, the two isoforms
of BRI3 were overexpressed in HEK-293T cells together
with the candidate proteins IFITM3 and MGAT1, which
were cloned into the pcDNA3-HA vector to express the
HA-tag fusion constructs. Immunoprecipitation was
performed from HEK-293T lysates by using HA-antibody
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and immunoblotting was done with GFP-antibody in
order to detect the GFP-fused versions of BRI3 isoforms.
BRI3BP (BRI3 binding protein) was used as a positive
control since it is an already known interacting partner of
BRI3 protein.
The results of coimmunoprecipitation experiments
indicated that the a-isoform of BRI3 is able to interact
both with the IFITM3 and MGAT1 proteins (Figure 3A
and Figure S1). In contrast, by comparing the protein
band intensities, it can be said that the b-isoform of BRI3
demonstrates a much weaker interaction with these two
candidate proteins and with the positive control BRI3BP,
as well (Figure 3B).
In order to visualize the possible interaction of
BRI3 isoforms with the candidate proteins MGAT1 and
IFITM3, colocalization assay was performed in the Huh7
hepatocellular carcinoma cell line. For this purpose, GFPtagged BRI3 isoforms were used together with dsREDtagged MGAT1 and IFITM3. The fluorescently tagged
proteins were expressed in Huh7 cells and 48 h after
transfection the cells were fixed and transferred onto glass
slides in order to be imaged with confocal microscopy.
As a result of the colocalization assay, the a-isoform
of BRI3 can be seen to colocalize with both MGAT1 and
IFITM3, especially in the perinuclear area and possibly
inside the organelles such as the Golgi apparatus or ER
(Figure 4A). On the other hand, the b-isoform of BRI3 is
mostly seen to be uniformly distributed throughout the
cell as being both in the cytoplasm and nucleus, rather
than having a specific subcellular localization. In that
case, a lower extent of colocalization is observed for the
b-isoform of BRI3 with either MGAT1 or IFITM3 (Figure
4B).
4. Discussion
The canonical Wnt/β-catenin pathway is a highly conserved
signaling pathway; it is involved in various differentiation
events during embryonic development, such as axis
formation, cellular proliferation, differentiation, and
morphogenesis. β-Catenin is considered to be the key
molecule in this pathway. In addition to its functions in
early vertebrate development, the Wnt/β-catenin pathway
has the potential to initiate tumor formation when
aberrantly activated. Those characteristics make the Wnt/
β-catenin signaling pathway itself and its targets important
subjects in cancer research fields, since genes regulated
by this pathway are potential drug and gene therapy
targets. Therefore, with the purpose of identifying novel
transcriptional targets of the Wnt/β-catenin pathway,
SAGE and microarray screenings were carried out in our
laboratory. Using these techniques, several genes were
determined to be either upregulated or downregulated
significantly in response to mimicking the active status of
the Wnt/β-catenin pathway.
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BRI3 was found to be one of the novel transcriptional
targets of the Wnt/β-catenin signaling pathway. It was
selected from the SAGE screening results due to the
fact that overexpression of the degradation-resistant
β-catenin mutant (S33Y-β-catenin) resulted in significant
upregulation of BRI3. Supporting data were obtained from
lithium treatment of Huh7 cell lines, luciferase reporter
assay, overexpression of Wnt ligands, and ChIP assay by
using the anti-β-catenin antibody (Kavak et al., 2010).
BRI3 has been poorly characterized so far, as can be
judged from the current literature. Its function and action
mechanism are largely unknown. Therefore, we aimed to
provide clues about the functional relevance of BRI3 for
the Wnt/β-catenin pathway. As a first step in our study, we
intended to discover novel interaction partners of the BRI3
protein in order to shed light on the action mechanism
of BRI3. Yeast two-hybrid assay was employed for this
purpose. A human liver cDNA library was screened using
BRI3 protein as bait. Following the two-hybrid library
screening by yeast mating, colonies were selected on highstringency growth media (-4 dropout media lacking Ade/
His/Leu/Trp amino acids) (Figure 1A). Identification
of the candidate interaction partners corresponding to
the positive colonies was performed by means of yeast
colony PCR and sequencing (Figure 1B). We were able to
identify MGAT1 (mannosyl α-1,3-glycoprotein β-1,4-Nacetylglucosaminyl transferase) and IFITM3 (interferon
induced transmembrane protein 3) as candidate positive
interactors, which were confirmed by cotransformation
into yeast cells. On the other hand, the third possible
candidate protein, IL-7R, was eliminated after yeast
cotransformation due to lack of colony growth on highstringency selective media.
With the purpose of verifying the interactions, further
experiments were performed using the two isoforms of
BRI3, which result from an alternative splicing event.
Alignment of the amino acid sequences of the two BRI3
isoforms suggest that the N-terminals are the same;
however, the BRI3 a-isoform has a distinct C-terminus
compared to the shorter BRI3 b-isoform (Figure 2).
Coimmunoprecipitation was performed in order to
test for the interaction of these BRI3 isoforms with the
candidate binding partners obtained from the yeast twohybrid assay. A strong positive interaction was determined
for the a-isoform of BRI3 with candidate proteins MGAT1
and IFITM3 (Figure 3A). However, in the case of the
shorter b-isoform of BRI3, very faint protein bands can
be observed in coimmunoprecipitation, suggesting a
much weaker interaction of the b-isoform with these two
candidate proteins (Figure 3B). BRI3BP was used as the
positive control for interaction since it was the only known
protein interactor of BRI3 (Yamazaki et al., 2007). A further
point is that, in the case of the BRI3 isoform-b, we could
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Figure 1. Experimental outline of the yeast two-hybrid assay. Yeast mating and screening of the resulting colonies on nutrient selective
media (A). Identification of candidate cDNA clones by colony PCR, sequencing, and confirmation by cotransformation into yeast cells (B).

not detect any band corresponding to isoform-b even for
the input samples in western blotting. The possible reason
for this is the failure of the BRI3 antibody to recognize
this shorter BRI3 isoform due to the differences in amino

acid sequences of these two isoforms, especially in their
C-terminals.
For further confirmation, a colocalization assay
was performed in Huh7 cell lines by expressing the
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Figure 2. Alignment and comparison of the amino acid sequences for the two isoforms of BRI3. Pairwise
sequence alignment was performed using EMBOSS Needle tool.

Figure 3. Coimmunoprecipitation of BRI3 a-isoform (A) and b-isoform (B) with the candidate proteins from HEK-293T cells using
HA-antibody and immunoblotting with anti-GFP antibody. BRI3BP is used as the positive control for the interaction.
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Figure 4. Confocal microscopy images of colocalization assay in Huh7 cells expressing GFP-tagged BRI3 a-isoform (A) and BRI3 bisoform (B) together with either MGAT1-dsRED or IFITM3-dsRED constructs.
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fluorescent-tagged proteins in order to visualize their
subcellular localizations. The results indicate an intense
colocalization of BRI3 with MGAT1, especially in the
perinuclear area of Huh7 cells, which might be inside an
organelle such as the Golgi apparatus or ER (Figure 4A).
In fact, a previous study was carried out to determine
the subcellular localization of BRI3 (Wu et al., 2003).
The results obtained from this study suggest that the
BRI3-GFP fusion protein localizes in the lysosomes
within the cell and the function of BRI3 may be related
to lysosomes. Colocalization was also observed between
the fluorescent-tagged proteins of BRI3 and IFITM3,
albeit to a lower extent (Figure 4A). On the other hand,
the BRI3 b-isoform appears to be distributed almost
uniformly throughout the cells, including both the
cytosol and nucleus, and additionally a very low level
of colocalization can be observed between the BRI3
b-isoform and candidate binding partners MGAT1 and
IFITM3 (Figure 4B). This observation prompts us to
hypothesize that the BRI3 protein might have a specific
localization signal sequence in its C-terminus, which is
not present in the shorter b-isoform.
MGAT1 is known to code for an enzyme essential
for the synthesis of hybrid and complex N-glycans. The
finding of MGAT1 as an interacting partner of BRI3 can
be regarded as promising in the sense that MGAT1 is also

one of the genes that exhibit differential expression levels
in response to β-catenin activation, as was demonstrated
in the initial SAGE analysis. Furthermore, our recent
experiments indicated that MGAT1 is upregulated at
both mRNA and protein levels in response to β-catenin
activation by various approaches. Thus, MGAT1 can be
defined as a novel transcriptional target of the Wnt/βcatenin signaling pathway (Akiva et al., 2018).
According to the previous literature, IFITM3 has
been identified as a new molecular marker in human
colorectal tumors and it has been stated that IFITM3
gene expression is controlled by Wnt/β-catenin signaling
in mouse and human intestinal epithelium (Andreu et
al., 2006). Furthermore, the results of a more recent study
indicated elevated IFITM3 expression in colon cancer
cells compared to normal colon cells. The data obtained
from this study suggest that IFITM3 plays an important
role in early colon cancer development (Fan et al., 2008).
In this study, we aimed to determine the novel
interaction partners of BRI3 by yeast two-hybrid assay.
In the course of this work, we have identified and
confirmed MGAT1 and IFITM3 as binding partners of
BRI3. Furthermore, all these three proteins are regulated
by Wnt/β-catenin signaling. The functional significance
of these novel interactions will be among the most
important subjects of future experiments.
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Table S1. List of proteins determined as putative interaction partners by yeast two-hybrid screening. “Sticky” proteins with abundant
expression levels in cDNA library are determined as false positive.
Gene symbol

Protein name

Description

IL-7R

Interleukin 7 receptor

Candidate interaction partner

MT2A

Metallothionein 2A

False positive

IFITM3

Interferon induced transmembrane protein 3

Candidate interaction partner

AOX1

Aldehyde oxidase 1

False positive

HEBP2

Heme-binding protein 2

False positive

VTN

Vitronectin

False positive

ALDOB

Aldolase B, fructose bisphosphate

False positive

HPX

Hemopexin

False positive

MGAT1

Mannosyl (α-1,3-)glycoprotein β-1,4-N-acetylglucosaminyltransferase

Candidate interaction partner

MT1X

Metallothionein 1X

False positive

TFR2

Transferrin receptor 2

False positive

TIMP1

TIMP metallopeptidase inhibitor 1

False positive

APOH

Apolipoprotein H (beta-2-glycoprotein I)

False positive

C8A

Complement component 8, alpha polypeptide

False positive

LRPAP1

Low density lipoprotein receptor-related protein associated protein 1

False positive

SLC2A4

Solute carrier family 2 (facilitated glucose transporter)

False positive

TM7SF3

Transmembrane 7 superfamily member 3

False positive

Figure S1. Coimmunoprecipitation of BRI3 a-isoform with the candidate proteins
MGAT1 and IFITM3 from HEK-293T cells using the HA-antibody and immunoblotting with anti-GFP, anti-BRI3, and anti-GAPDH antibodies. BRI3BP is used as
positive control for the interaction. Anti-Epcam antibody is used as a mock antibody
(negative control for immunoprecipitation).
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